Design, synthesis and evaluation of quinolinone derivatives containing dithiocarbamate moiety as multifunctional AChE inhibitors for the treatment of Alzheimer’s disease

References

• Sharma P, Srivastava P, Seth A, et al. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies. Prog Neurobiol 2019;174:53–89.
   PubMed Web of Science ®Google Scholar
• Patterson C. World Alzheimer Report 2018—The state of the art of dementia research: New frontiers. London: Alzheimer’s Disease International (ADI); 2018.
   Google Scholar
• Prince M, Comas-Herrera A, Knapp M, et al. World Alzheimer report 2016: Improving healthcare for people living with dementia: coverage, quality and costs now and in the future. London: Alzheimer’s Disease International (ADI); 2016.
   Google Scholar
• Hampel H, Mesulam MM, Cuello AC, et al. Revisiting the cholinergic hypothesis in Alzheimer's disease: emerging evidence from translational and clinical research. J Prev Alzheimers Dis 2019;6:2–15.
   PubMed Web of Science ®Google Scholar
• Contestabile A. The history of the cholinergic hypothesis. Behav Brain Res 2011;221:334–40.
   PubMed Web of Science ®Google Scholar
• Hasselmo ME. The role of acetylcholine in learning and memory. Curr Opin Neurobiol 2006;16:710–5.
   PubMed Web of Science ®Google Scholar
• Pepeu G, Giovannini MG. Cholinesterase inhibitors and beyond. Curr Alzheimer Res 2009;6:86–96.
   PubMed Web of Science ®Google Scholar
• Marco JL, Carreiras MC. Recent developments in the synthesis of acetylcholinesterase inhibitors. Mini Rev Med Chem 2003;3:518–24.
   PubMed Web of Science ®Google Scholar
• Reiman EM. Alzheimer's disease: Attack on amyloid-β protein. Nature 2016;537:36–7.
   PubMed Web of Science ®Google Scholar
• Korczyn AD. The amyloid cascade hypothesis. Alzheimers Dement 2008;4:176–8.
   PubMed Web of Science ®Google Scholar
• Bayer TA, Wirths O. Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease. Acta Neuropathol 2014;127:787–801.
   PubMed Web of Science ®Google Scholar
• Reitz C. Alzheimer's disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimers Dis 2012;2012:369808.
   PubMedGoogle Scholar
• Bartolini M, Bertucci C, Cavrini V, et al. beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 2003;65:407–16.
   PubMed Web of Science ®Google Scholar
• Harel M, Kleywegt GJ, Ravelli RB, et al. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target. Structure 1995;3:1355–66.
   PubMed Web of Science ®Google Scholar
• Inestrosa NC, Urra S, Colombres M. Acetylcholinesterase (AChE)–amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway. Curr Alzheimer Res 2004;1:249–54.
   PubMedGoogle Scholar
• Nalivaeva NN, Turner AJ. AChE and the amyloid precursor protein (APP) – Cross-talk in Alzheimer's disease. Chem Biol Interact 2016;259:301–6.
   PubMed Web of Science ®Google Scholar
• Kaur K, Jain M, Reddy RP, et al. Quinolines and structurally related heterocycles as antimalarials. Eur J Med Chem 2010;45:3245–64.
   PubMed Web of Science ®Google Scholar
• Audisio D, Messaoudi S, Cojean S, et al. Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives. Eur J Med Chem 2012;52:44–50.
   PubMed Web of Science ®Google Scholar
• Sang Z, Pan W, Wang K, et al. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. Bioorg Med Chem 2017;25:3006–17.
   PubMed Web of Science ®Google Scholar
• Farina R, Pisani L, Catto M, et al. Structure-Based design and optimization of Multitarget-Directed 2H-Chromen-2-one derivatives as potent inhibitors of monoamine Oxidase B and cholinesterases. J Med Chem 2015;58:5561–78.
   PubMed Web of Science ®Google Scholar
• He Q, Liu J, Lan JS, et al. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation. Bioorg Chem 2018;81:512–28.
   PubMed Web of Science ®Google Scholar
• Jiang N, Huang Q, Liu J, et al. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem 2018;146:287–98.
   PubMed Web of Science ®Google Scholar
• Chilin A, Rodighiero P, Pastorini G, et al. New synthesis of pyrrolo [3, 2, 1-ij] quinolin-4-one derivatives. J Org Chem 1991;56:980–3.
   Web of Science ®Google Scholar
• Xie L, Qian X, Cui J, et al. Novel angular furoquinolinones bearing flexible chain as antitumor agent: design, synthesis, cytotoxic evaluation, and DNA-binding studies. Bioorg Med Chem 2008;16:8713–8.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Fan K, et al. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 2003;38:223–32.
   PubMed Web of Science ®Google Scholar
• Camps P, Formosa X, Galdeano C, et al. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation. J Med Chem 2008;51:3588–98.
   PubMed Web of Science ®Google Scholar
• Kwon YE, Park JY, No KT, et al. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics. Bioorg Med Chem 2007;15:6596–607.
   PubMed Web of Science ®Google Scholar
• Xu P, Zhang M, Sheng R, et al. Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, Abeta1-42 aggregation inhibitors and metal-chelating agents for Alzheimer's disease. Eur J Med Chem 2017;127:174–86.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang K, Zhang K, et al. Puerarin protects human neuroblastoma SH-SY5Y cells against Glutamate-Induced oxidative stress and mitochondrial dysfunction. J Biochem Mol Toxicol 2016;30:22–8.
   PubMed Web of Science ®Google Scholar
• Ng'uni T, Klaasen JA, Fielding BC. Acute toxicity studies of the South African medicinal plant Galenia africana. Toxicol Rep 2018;5:813–8.
   PubMed Web of Science ®Google Scholar
• Jiang N, Ding J, Liu J, et al. Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with beta-amyloid anti-aggregation properties for the treatment of Alzheimer's disease. Bioorg Chem 2019;89:103027.
   PubMed Web of Science ®Google Scholar
• Najafi Z, Mahdavi M, Saeedi M, et al. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study. Bioorg Chem 2019;83:303–16.
   PubMed Web of Science ®Google Scholar
• Xie SS, Lan JS, Wang X, et al. Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease. Bioorg Med Chem 2016;24:1528–39.
   PubMed Web of Science ®Google Scholar
• Hiremathad A, Keri RS, Esteves AR, et al. Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease. Eur J Med Chem 2018;148:255–67.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005;2:3–14.
   PubMedGoogle Scholar
• Kingwell K. Drug delivery: new targets for drug delivery across the BBB. Nat Rev Drug Discov 2016;15:84–5.
   PubMed Web of Science ®Google Scholar
• Li AP. Accurate prediction of human drug toxicity: a major challenge in drug development. Chem Biol Interact 2004;150:3–7.
   PubMed Web of Science ®Google Scholar